tradingkey.logo
搜索

Abcellera Biologics Inc

ABCL
添加自选
5.715USD
+0.025+0.44%
收盘 07-31 16:00美东报价延迟15分钟
1.74B总市值
亏损市盈率 TTM

ABCL 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Abcellera Biologics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Abcellera Biologics Inc财报日历

最新发布
8月 5, 2026
每股收益 / 预测值
--/-0.14
营业收入 / 预测值
--/7.78M
报告期
FY2025 财报
营业收入(YoY)
75.13M
160.56%
每股收益(YoY)
-0.49
11.42%
分析师评级
BUY
2026/07/31
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
7.07%-0.14
74.22%-0.03
-10.26%-0.19
7.31%-0.12
-10.47%-0.15
28.70%-0.12
-75.38%-0.17
-18.78%-0.13
0.47%-0.14
-55.49%-0.16
---0.10
---0.11
---0.14
---0.10
--0.66
----
----
----
----
----
营业收入
96.34%8.31M
788.18%44.85M
37.62%8.96M
133.29%17.08M
-57.45%4.24M
-44.98%5.05M
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-57.40%9.18M
-93.49%6.60M
-78.10%10.06M
-96.15%12.19M
-84.54%21.55M
1740.65%101.38M
66.11%45.92M
56.15%316.58M
-32.98%139.33M
--5.51M
146.20%27.64M
净利润
5.38%-43.16M
73.85%-8.95M
-11.76%-57.12M
5.97%-34.73M
-12.34%-45.62M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
-149.86%-29.89M
224.53%26.62M
-192.08%-6.79M
43.81%168.57M
-48.76%59.95M
---21.38M
-134.66%-2.32M
利润率
51.81%-519.12%
97.06%-19.94%
18.79%-637.84%
59.69%-203.27%
-164.04%-1077.24%
-31.88%-677.43%
-81.16%-785.42%
-66.12%-504.30%
-24.01%-407.98%
-270.22%-513.67%
---433.55%
---303.58%
---328.99%
---138.75%
--40.62%
----
----
----
----
----
毛利率
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
资产负债率
----
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
----
----
营业收入
96.34%8.31M
788.18%44.85M
37.62%8.96M
133.29%17.08M
-57.45%4.24M
-44.98%5.05M
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-57.40%9.18M
-93.49%6.60M
-78.10%10.06M
-96.15%12.19M
-84.54%21.55M
1740.65%101.38M
66.11%45.92M
56.15%316.58M
-32.98%139.33M
--5.51M
146.20%27.64M
营业利润
8.20%-57.52M
60.71%-28.58M
-23.70%-76.28M
19.31%-49.59M
-14.15%-62.66M
-15.75%-72.75M
-12.34%-61.66M
-19.59%-61.45M
15.38%-54.89M
-66.37%-62.85M
-245.46%-54.89M
-512.07%-51.39M
-128.84%-64.87M
-146.32%-37.78M
234.31%37.73M
-19.38%-8.40M
42.31%224.95M
-49.27%81.55M
---28.10M
-723.54%-7.03M
净利润
5.38%-43.16M
73.85%-8.95M
-11.76%-57.12M
5.97%-34.73M
-12.34%-45.62M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
-149.86%-29.89M
224.53%26.62M
-192.08%-6.79M
43.81%168.57M
-48.76%59.95M
---21.38M
-134.66%-2.32M
流动资产
-13.12%664.60M
-3.08%728.23M
-6.43%695.14M
-3.81%742.14M
-6.02%764.98M
-13.83%751.37M
-19.21%742.88M
-17.10%771.55M
-13.47%813.95M
-14.97%871.99M
-12.06%919.52M
-18.64%930.74M
-19.90%940.65M
10.29%1.03B
30.10%1.05B
32.40%1.14B
29.34%1.17B
14.32%929.80M
605.04%803.75M
--864.00M
流动负债总额
-37.27%47.29M
-16.06%64.31M
-13.53%68.80M
-4.77%67.02M
-28.11%75.40M
-35.63%76.61M
-27.82%79.57M
-40.81%70.38M
17.07%104.88M
0.59%119.01M
3.95%110.24M
-46.23%118.91M
-58.02%89.59M
-1.95%118.32M
114.03%106.05M
217.01%221.14M
141.44%213.42M
16.61%120.68M
146.46%49.55M
--69.76M
总资产
-2.76%1.31B
-0.26%1.36B
-2.64%1.36B
-0.74%1.40B
-8.13%1.34B
-8.57%1.36B
-7.89%1.39B
-8.11%1.41B
-2.32%1.46B
-3.43%1.49B
-2.59%1.51B
-3.55%1.54B
-5.93%1.50B
16.86%1.54B
32.38%1.55B
38.37%1.59B
41.09%1.59B
31.13%1.32B
723.63%1.17B
--1.15B
总负债
14.88%369.03M
28.11%390.05M
24.54%391.95M
31.00%394.99M
-3.59%321.23M
-9.32%304.47M
-4.46%314.73M
-11.93%301.51M
15.12%333.18M
9.15%335.78M
8.99%329.42M
-10.13%342.34M
-24.78%289.42M
5.05%307.63M
37.80%302.24M
106.83%380.93M
124.49%384.78M
67.31%292.84M
312.69%219.34M
--184.18M
总权益
-8.30%938.08M
-8.44%966.90M
-10.58%964.04M
-9.35%1.01B
-9.46%1.02B
-8.35%1.06B
-8.85%1.08B
-7.02%1.11B
-6.50%1.13B
-6.56%1.15B
-5.39%1.18B
-1.49%1.19B
0.08%1.21B
20.23%1.23B
31.13%1.25B
25.34%1.21B
26.16%1.21B
23.51%1.03B
968.37%953.40M
--967.68M
经营净额
-190.14%-33.52M
-334.29%-34.74M
-82.10%-52.59M
-8.14%-32.40M
72.30%-11.55M
59.21%-8.00M
-27147.17%-28.88M
-250.56%-29.97M
5.34%-41.71M
-163.44%-19.61M
99.92%-106.00K
-92.71%19.90M
-143.97%-44.06M
284.97%30.91M
-2037.32%-126.79M
73.14%273.01M
-8.51%100.22M
-1409.32%-16.71M
---5.93M
--157.68M
投资净额
-416.08%-25.08M
110.45%75.14M
886.70%36.49M
-161.06%-31.81M
-73.47%7.94M
246.79%35.70M
128.92%3.70M
251.49%52.10M
119.99%29.91M
-42.55%-24.32M
95.47%-12.79M
-26.45%-34.39M
-467.32%-149.61M
-1385.03%-17.06M
-4.59%-281.99M
40.40%-27.20M
-66.49%-26.37M
98.94%-1.15M
---269.63M
---45.63M
融资净额
20.47%7.19M
-0.65%4.12M
134.40%7.37M
-227.31%-3.38M
110.88%5.97M
10.01%4.14M
-52.56%3.15M
532.70%2.65M
718.12%2.83M
978.80%3.77M
34994.74%6.63M
-64.28%419.00K
85.37%-458.00K
-80.97%349.00K
-102.12%-19.00K
123.11%1.17M
-102.92%-3.13M
-99.70%1.83M
--898.00K
---5.08M

常见问题

Abcellera Biologics Inc的总收入是多少?

根据Abcellera Biologics Inc的FY2025财报,总收入达到了75.13M(同比变化28.83M)。

Abcellera Biologics Inc的流动资产是多少?

根据Abcellera Biologics Inc的FY2025财报,流动资产为728.23M(同比变化-3.08)。

Abcellera Biologics Inc的总资产是多少?

根据Abcellera Biologics Inc的FY2025财报,Abcellera Biologics Inc的总资产为1.36B(同比变化-0.26)。

Abcellera Biologics Inc的总负债是多少?

根据Abcellera Biologics Inc的FY2025财报,Abcellera Biologics Inc的总负债为390.05M(同比变化28.11)。

Abcellera Biologics Inc的总权益是多少?

根据Abcellera Biologics Inc的FY2025财报,Abcellera Biologics Inc的总权益为966.90M(同比变化-8.44)。

Abcellera Biologics Inc的净营业收入是多少?

根据Abcellera Biologics Inc的FY2025财报,Abcellera Biologics Inc的净营业收入为-217.10M(同比变化13.42)。

Abcellera Biologics Inc的净投资是多少?

根据Abcellera Biologics Inc的FY2025财报,Abcellera Biologics Inc的净投资为87.75M(同比变化-27.72)。

Abcellera Biologics Inc的净融资是多少?

根据Abcellera Biologics Inc的FY2025财报,Abcellera Biologics Inc的净融资为14.08M(同比变化10.28)。

Abcellera Biologics Inc的每股收益(EPS)是多少?

根据Abcellera Biologics Inc的FY2025财报,每股收益(EPS)为-0.49(同比变化11.42)。

Abcellera Biologics Inc的净利润是多少?

根据Abcellera Biologics Inc的FY2025财报,净利润为-146.41M(同比变化10.10)。

Abcellera Biologics Inc的净利润率是多少?

根据Abcellera Biologics Inc的FY2025财报,净利润率为-194.88(同比变化65.50)。

Abcellera Biologics Inc的股东权益回报率(ROE)是多少?

根据Abcellera Biologics Inc的FY2025财报,股东权益回报率(ROE)为-14.47(同比变化1.86)。

Abcellera Biologics Inc的资产回报率(ROA)是多少?

根据Abcellera Biologics Inc的FY2025财报,资产回报率(ROA)为-10.78(同比变化5.76)。

Abcellera Biologics Inc的营业利润是多少?

根据Abcellera Biologics Inc的FY2025财报,营业利润为-217.10M(同比变化13.42)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有